Cancer Care Program
AI-driven oncology care support with medication adherence tracking
Company profile
Company profile
Memora Health is a leading intelligent care enablement platform that transforms how healthcare organizations deliver care to patients across complex clinical journeys. The company's AI-powered platform integrates with existing healthcare technology to automate routine clinical workflows, enabling care teams to focus on top-of-license practice while providing patients with proactive, personalized support. Memora's conversational AI handles patient inquiries, monitors symptoms, tracks medication adherence, and collects patient-reported outcomes, intelligently triaging complex issues to appropriate care team members when needed. The platform serves multiple clinical areas including maternal care, surgical care, gastrointestinal care, cancer care, chronic care management, population health, and transitions of care. Memora partners with leading health systems, health plans, and digital health companies to deliver measurable impact, with 85% of patient inquiries resolved by AI assistants and 95% patient engagement rates. The company's technology enables healthcare organizations to scale value-based care programs while reducing administrative burden on providers. Now part of Commure, Memora Health continues to advance its mission of making care more actionable, accessible, and always-on for both patients and care teams.
Company description Memora Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Acquired by Commure (date not specified); Partnership with Intermountain Health announced March 2024 for multi-year enterprise deployment starting with oncology; Named to 2023 CB Insights Digital Health 50 List
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-driven oncology care support with medication adherence tracking
Scalable chronic disease management with adherence tracking and VBC reporting
AI-enabled patient engagement for GI procedures and care optimization
AI-powered care management with remote monitoring and automated patient engagement
Digital health solution for maternity care and 4th trimester support
AI-backed platform that digitizes and automates care programs for patients and care teams
Enterprise-wide population health management with AI-backed engagement
Digital care coordination for surgical patients and post-operative monitoring
AI-powered care coordination for hospital discharge and care transitions
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
JMIR AI · Apr 22, 2025
Overcoming Barriers to Make Patient-Reported Outcome Collection the Standard of Care in Oncology.JAMA oncology · Mar 1, 2025
Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine.JCO oncology practice · Apr 1, 2024
Cascade Services and Spending Following Low-Value Imaging for Uncomplicated Low Back Pain among Commercially Insured Adults.Journal of general internal medicine · Mar 1, 2023
Clinical validation
NCT06510075 · Sponsor · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Average across programs on latest AI model
Enrolled patients engaged with Memora platform
Oncology program with not-for-profit health system
Postpartum program with academic medical center
Multi-year partnership to implement innovative care delivery programs starting with cancer care, with plans to extend across additional clinical areas
Scaling personalized, high-quality care while streamlining workflows for care teams across 33 hospitals and 385 clinics
Postpartum program implementation
92% patient satisfaction rating
Using SMS-based intelligent care enablement platform to improve ePRO collection and implement innovative Orthopedic program for post-discharge clinical symptom assessment
Using AI-backed platform to optimize oncology care journeys for patients and care teams
Using conversational two-way SMS to transform care delivery throughout transitions of care, particularly in women and infant services
GI program implementation
95% of enrolled patients engaged with Memora
Oncology program for medication adherence
96% medication adherence among patients
Deploying AI-enabled technology to optimize patient engagement and boost efficiency across care teams for GI procedures
05 · Leadership
Leadership profiles and professional links from the current Company record.
Omar Nagji
Chief Commercial Officer
Gordon Rosen
VP, Enterprise
06 · Company updates
Recent articles published on Memora Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to engage patients, provide health education, facilitate peer support, offer AI health coaching, or help patients navigate their healthcare journey. Includes patient communities, AI health mentors, peer support networks, and platforms that empower patients to take an active role in managing their own health.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.